Baqar S, Bourgeois A L, Applebee L A, Mourad A S, Kleinosky M T, Mohran Z, Murphy J R
Department of Infectious Diseases, Naval Medical Research Institute, Bethesda, Maryland 20889-5607, USA.
Infect Immun. 1996 Dec;64(12):4933-9. doi: 10.1128/iai.64.12.4933-4939.1996.
Campylobacter jejuni infection of mice initiated by intranasal administration was investigated as a potential model for studies of pathogenesis and immunity. By using a standard challenge (5 x 10(9) CFU), C. jejuni 81-176 was more virulent for BALB/c (72% mortality) than for C3H/Hej (50%), CBA/CAJ (30%), or C58/J (0%). Intranasal challenge of BALB/c was used to compare the relative virulence of three reference strains; C.jejuni 81-176 was more virulent (killing 83% of challenged mice) than C. jejuni HC (0%) or C. coli VC-167 (0%). The course of intranasally initiated C. jejuni 81-176 infection in BALB/c was determined. C. jejuni was recovered from the lungs, intestinal tract, liver, and spleen at 4 h after challenge, the first interval evaluated. After this initial interval, three distinct patterns of infection were recognized: (i) a progressive decline in number of C. jejuni CFU (stomach, blood, lungs), (ii) decline followed by a second peak in the number of organisms recovered at 2 or 3 days postchallenge (intestine, liver, mesenteric lymph nodes), and (iii) persistence of approximately the same number of C.jejuni CFU during the course of the experiment (spleen). Intranasally induced infection initiated with a sublethal number of bacteria or intranasal immunization with killed Campylobacter preparations resulted in both the generation of Campylobacter antigen-specific immune responses and an acquired resistance to homologous rechallenge. The model was used to evaluate the relative virulence of nine low-in vitro-passage (no more than five passages) isolates of C. jejuni species from patients with diarrhea. The patient isolates were differentially virulent for mice; one killed all exposed mice, three were avirulent (no deaths) and the remainder showed an intermediate virulence, killing 17 to 33%. Mouse virulence of Campylobacter strains showed a trend toward isolates originating from individuals with watery diarrhea; however, no association was found between mouse virulence and other signs or symptoms. There were no observed relationships between mouse virulence and bacterial Lior serotype or Fla polymorphic group. Intranasal challenge of BALB/c with C. jejuni is a useful model for the study of infection and vaccination-acquired immunity to this agent.
研究了通过鼻内给药引发的空肠弯曲菌感染小鼠,将其作为研究发病机制和免疫的潜在模型。使用标准挑战剂量(5×10⁹CFU),空肠弯曲菌81 - 176对BALB/c小鼠(死亡率72%)的毒性比对C3H/Hej小鼠(50%)、CBA/CAJ小鼠(30%)或C58/J小鼠(0%)更强。用BALB/c小鼠进行鼻内攻击以比较三种参考菌株的相对毒力;空肠弯曲菌81 - 176比空肠弯曲菌HC(0%)或大肠弯曲菌VC - 167(0%)的毒性更强(杀死83%的受攻击小鼠)。确定了在BALB/c小鼠中鼻内引发的空肠弯曲菌81 - 176感染过程。在攻击后4小时(评估的第一个时间间隔)从肺、肠道、肝脏和脾脏中分离出空肠弯曲菌。在这个初始时间间隔之后,识别出三种不同的感染模式:(i)空肠弯曲菌CFU数量逐渐下降(胃、血液、肺),(ii)下降后在攻击后2或3天回收的生物体数量出现第二个峰值(肠道、肝脏、肠系膜淋巴结),以及(iii)在实验过程中空肠弯曲菌CFU数量大致保持不变(脾脏)。用亚致死数量的细菌进行鼻内诱导感染或用灭活的弯曲菌制剂进行鼻内免疫,既导致了弯曲菌抗原特异性免疫反应的产生,也产生了对同源再攻击的获得性抗性。该模型用于评估来自腹泻患者的九株低体外传代(不超过五代)空肠弯曲菌种分离株的相对毒力。患者分离株对小鼠的毒力不同;一株杀死了所有暴露的小鼠,三株无毒力(无死亡),其余表现出中等毒力,杀死17%至33%的小鼠。弯曲菌菌株对小鼠的毒力显示出一种趋势,即源自水样腹泻个体的分离株;然而,在小鼠毒力与其他体征或症状之间未发现关联。在小鼠毒力与细菌Lior血清型或Fla多态性组之间未观察到关系。用空肠弯曲菌对BALB/c小鼠进行鼻内攻击是研究该病原体感染和疫苗接种获得性免疫的有用模型。